Unknown

Dataset Information

0

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.


ABSTRACT: Antibodies are becoming a frontline therapy for SARS-CoV-2, but the risk of viral evolutionary escape remains unclear. Here we map how all mutations to SARS-CoV-2's receptor-binding domain (RBD) affect binding by the antibodies in Regeneron's REGN-COV2 cocktail and Eli Lilly's LY-CoV016. These complete maps uncover a single amino-acid mutation that fully escapes the REGN-COV2 cocktail, which consists of two antibodies targeting distinct structural epitopes. The maps also identify viral mutations that are selected in a persistently infected patient treated with REGN-COV2, as well as in lab viral escape selections. Finally, the maps reveal that mutations escaping each individual antibody are already present in circulating SARS-CoV-2 strains. Overall, these complete escape maps enable immediate interpretation of the consequences of mutations observed during viral surveillance.

SUBMITTER: Starr TN 

PROVIDER: S-EPMC7724661 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7963219 | biostudies-literature
| S-EPMC5363992 | biostudies-literature
| S-EPMC5895760 | biostudies-literature
| S-EPMC6711711 | biostudies-literature
| S-EPMC8263750 | biostudies-literature
| S-EPMC6146816 | biostudies-literature
| S-EPMC7987023 | biostudies-literature
| S-EPMC8451977 | biostudies-literature
| S-EPMC8323339 | biostudies-literature
| S-EPMC8486678 | biostudies-literature